Details of the Drug
General Information of Drug (ID: DM45N6U)
Drug Name |
4-Methylimidazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Methylimidazole; 4-Methyl-1H-imidazole; 822-36-6; 5-Methyl-1H-imidazole; 1H-Imidazole, 4-methyl-; 4(5)-Methylimidazole; 4-Me-i; 5-Methylimidazole; IMIDAZOLE, 4-METHYL-; 4(or 5)-Methylimidazole; 4-MEI; 4-methylimidazol; UNII-Q64GF9FV4I; 1H-Imidazole, 5-methyl-; 4-methyl imidazole; EINECS 212-497-3; NSC 40744; Q64GF9FV4I; AI3-08274; CHEBI:40035; XLSZMDLNRCVEIJ-UHFFFAOYSA-N; 4-Methylimidazole, 98%; 4-Methyl-d3-imidazole; 88054-16-4; 4MI; 4MZ; InChI=1/C4H6N2/c1-4-2-5-3-6-4/h2-3H,1H3,(H,5,6; CCRIS 8912; HSDB 7757; 4-methyl-imidazole
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 82.1 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||